Advice
Indication withdrawn
The marketing authorisation for collagense clostridum histolyticum (Xiapex) has been withdrawn – see link
Medicine details
- Medicine name:
- collagenase clostridum histolyticum (Xiapex)
- SMC ID:
- 1059/15
- Indication:
Treatment of adult men with Peyronie' s disease with a palpable plaque and curvature deformity of at least 30 degrees at the start of therapy.
- Pharmaceutical company
- Swedish Orphan
- BNF chapter
- Musculoskeletal and joint diseases
- Submission type
- Non submission
- Status
- Withdrawn
- Date advice published
- 11 May 2015
Additional notes
The marketing authorisation for collagense clostridum histolyticum (Xiapex) has been withdrawn – see link